Autonomize AI, an Austin, TX-based artificial intelligence (AI) company for healthcare and life sciences, raised $4M in Seed funding.
The round was led by Asset Management Ventures, with participation from ATX Venture Partners, Loop Ventures and The Next Practices Group.
The company intends to use the funds to boost its R&D and commercialization efforts.
Led by CEO and Founder Ganesh Padmanabhan, Autonomize AI specializes in AI solutions for healthcare and life-sciences organizations. Its platform uses large language models to analyze and interpret unstructured data, with evidence and explainability, and offers key generative AI capabilities to summarize and visualize information in a clear and concise manner.
Its products include:
- Autonomize Pixel, which accelerates clinical trials through more efficient workflows and optimal protocol design, feasibility studies and patient matching.
- Autonomize Wizard, which augments clinical decisions by providing multi-modal chart insights for research, payer administration, registries and decision-making.
- Generative AI, which offers conversational, search and summarization capabilities for secure internal data sources, contextualized for different user types.
FinSMEs
03/05/2023